B. Chernyak

Most-cited papers

1. Federal clinical guidelines on diagnosis and treatment of idiopathic pulmonary fibrosis

   S. Avdeev, Z. Aisanov, A. Belevskiy, M. Ilkovich +14 more

   2022PULMONOLOGIYA24 citations Open access

   Semantic Scholar

   Save

2. Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia

   M. S. Nashatyreva, I. Trofimenko, B. Chernyak, S. Avdeev

   2023Life17 citations Open access

   Semantic Scholar

   Save

3. Differential expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in bronchial mucosa of patients with asthma and chronic obstructive pulmonary disease.

   P. A. Selivanova, E. Kulikov, O. Kozina, I. Trofimenko +3 more

   2012Annals of Allergy, Asthma & Immunology14 citations

   Semantic Scholar

   Save

4. Relationship between total and specific IgE in patients with asthma from Siberia.

   Elena S. Gusareva, L. M. Ogorodova, B. Chernyak, M. Lipoldová

   2008Journal of Allergy and Clinical Immunology7 citations

   Semantic Scholar

   Save

5. Chromosome 12q24.3 controls sensitization to cat allergen in patients with asthma from Siberia, Russia.

   Elena S. Gusareva, Elena Bragina, S. N. Buinova, B. Chernyak +3 more

   2009Immunology Letters4 citations Open access

   Semantic Scholar

   Save

6. Hypersensitive pneumonitis: from etiology and pathogenesis to diagnosis and treatment

   B. Chernyak, I. Vorzheva, I. Trofimenko, Irkutsk Russia Pulmonology

   2021Pharmateca3 citations

   Semantic Scholar

   Save

7. ASPIRIN-EXACERBATED RESPIRATORY DISEASE: MECHANISMS OF DEVELOPMENT, DIAGNOSTICS AND TREATMENT

   I. Vorzheva, B. Chernyak

   2018Pharmateca3 citations

   Semantic Scholar

   Save

8. Chronic fibrosing interstitial lung diseases according to the register of Irkutsk (Russia)

   M. S. Nashatyreva, I. Trofimenko, B. Chernyak

   2022PULMONOLOGIYA2 citations Open access

   Semantic Scholar

   Save

9. Possibilities to prevent acute exacerbation of chronic obstructive pulmonary disease using inhalational therapy. A Report of Expert Panel of Russian Respiratory Society

   S. Avdeev, A. Belevskiy, Z. Aisanov, V. Arkhipov +12 more

   2018Russian Pulmonology2 citations Open access

   Semantic Scholar

   Save

10. “AMIODARONE” LUNG: LITERATURE REVIEW AND AUTHORS’ OWN OBSERVATIONS

    I. Trofimenko, B. Chernyak

    20181 citations

    Semantic Scholar

    Save

11. CLINICAL AND FUNCTIONAL FEATURES OF THE EVOLUTION OF BRONCHIAL ASTHMA IN YOUNG PATIENTS, WHO SUFFER WITH THE DISEASE FROM CHILDHOOD

    B. Chernyak, A. Ivanov

    20131 citations

    Semantic Scholar

    Save

12. Modern concepts of drug hypersensitivity: a series of lectures for medical practitioners. Lecture 1

    I. Vorzheva, B. Chernyak

    20210 citations

    Semantic Scholar

    Save

13. “Methotrexate lung”: a look at the problem today

    I. Trofimenko, B. Chernyak

    2021Pharmateca0 citations

    Semantic Scholar

    Save

14. Efficacy of long-term treatment with mepolizumab in severe eosinophilic asthma (case reports)

    B. Chernyak, I. Vorzheva, A. Ivanov

    2019Russian Pulmonology0 citations Open access

    Semantic Scholar

    Save

15. Lung lesions in connective tissue diseases

    I. Trofimenko, B. Chernyak

    2019Russian Pulmonology0 citations Open access

    Semantic Scholar

    Save

16. The effect of bronchial hyperreactivity on the quality of life of patients with chronic obstructive pulmonary disease

    I. Trofimenko, B. Chernyak

    2019Pharmateca0 citations

    Semantic Scholar

    Save

17. The efficacy and safety of mepolizumab in severe eosinophilic asthma: a literature review

    B. Chernyak, I. Vorzheva

    2019Pharmateca0 citations

    Semantic Scholar

    Save

18. Dynamics of the prevalence of allergic rhinitis in children of Irkutsk

    S. N. Buinova, B. Chernyak

    20190 citations Open access

    Semantic Scholar

    Save

19. Epidemiological characteristics of bronchial asthma in children of Irkutsk characteristics

    S. N. Buinova, B. Chernyak

    20190 citations Open access

    Semantic Scholar

    Save

20. Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice

    A. Ivanov, B. Chernyak

    20180 citations Open access

    Semantic Scholar

    Save

21. Risk factors of bronchial hyperresponsiveness in COPD

    I. Trofimenko, B. Chernyak

    20150 citations

    Semantic Scholar

    Save

22. Comparison of protective effect of bronchodilators in COPD

    I. Trofimenko, B. Chernyak

    20150 citations

    Semantic Scholar

    Save

23. INFLUENCE OF BRONCHODILATORS ON BRONCHIAL HYPERRESPONSIVENESS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    I. Trofimenko, B. Chernyak

    20140 citations

    Semantic Scholar

    Save

24. Bronchial hyperresponsiveness as a phenotypic feature of chronic obstructive pulmonary disease

    I. Trofimenko, B. Chernyak

    20140 citations Open access

    Semantic Scholar

    Save

25. Determinants of severity of dyspnea in COPD

    I. Trofimenko, B. Chernyak

    20130 citations

    Semantic Scholar

    Save

26. Bronchial hyperresponsiveness as a predictor of treatment-response in COPD

    I. Trofimenko, B. Chernyak

    2013European Respiratory Journal0 citations

    Semantic Scholar

    Save

27. Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD

    I. Trofimenko, B. Chernyak

    20120 citations

    Semantic Scholar

    Save

28. Association of inflammation and bronchial hyperresponsiveness

    I. Trofimenko, B. Chernyak

    20110 citations

    Semantic Scholar

    Save

29. Bronchial hyperresponsiveness as phenotypic feature of COPD

    I. Trofimenko, B. Chernyak

    2011European Respiratory Journal0 citations

    Semantic Scholar

    Save

30. DYSPNEA IN COPD PATIENTS: THE RELATIONSHIP WITH FUNCTIONAL STATUS, QUALITY OF LIFE IN DYNAMICS OF TREATMENT WITH TIOTROPIUM

    B. Chernyak, I. Tro

    20100 citations

    Semantic Scholar

    Save